India ramps up Ebola vaccine production amid Africa outbreak: Report
India is set to play a key role in the global response to the ongoing Ebola outbreak in Central Africa, with the Serum Institute of India (SII) fast-tracking the development and production of a vaccine candidate targeting the Bundibugyo strain of the virus, according to a report.
A report by Modern Diplomacy showed that the initiative is being undertaken in collaboration with the University of Oxford and the Coalition for Epidemic Preparedness Innovations (CEPI), with support from the World Health Organization (WHO) and the Africa Centres for Disease Control and Prevention (Africa CDC).
The vaccine candidate -- known as ChAdOx1 BDBV -- is designed to protect against the Bundibugyo ebolavirus, a relatively rare strain currently linked to the outbreak in the Democratic Republic of Congo (...

